Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol.

Laaser U, Breckenkamp J (2006)
European Journal of Public Health 16(2): 217-222.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
;
Erscheinungsjahr
Zeitschriftentitel
European Journal of Public Health
Band
16
Ausgabe
2
Seite(n)
217-222
ISSN
eISSN
PUB-ID

Zitieren

Laaser U, Breckenkamp J. Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol. European Journal of Public Health. 2006;16(2):217-222.
Laaser, U., & Breckenkamp, J. (2006). Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol. European Journal of Public Health, 16(2), 217-222. doi:10.1093/eurpub/cki062
Laaser, U., and Breckenkamp, J. (2006). Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol. European Journal of Public Health 16, 217-222.
Laaser, U., & Breckenkamp, J., 2006. Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol. European Journal of Public Health, 16(2), p 217-222.
U. Laaser and J. Breckenkamp, “Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol.”, European Journal of Public Health, vol. 16, 2006, pp. 217-222.
Laaser, U., Breckenkamp, J.: Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol. European Journal of Public Health. 16, 217-222 (2006).
Laaser, Ulrich, and Breckenkamp, Jürgen. “Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol.”. European Journal of Public Health 16.2 (2006): 217-222.

10 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Prevalence of dyslipidaemia and awareness of blood cholesterol levels among community-living people: results from the Longevity check-up 7+ (Lookup 7+) cross-sectional survey.
Marzetti E, Calvani R, Picca A, Sisto A, Tosato M, Martone AM, Ortolani E, Salini S, Pafundi T, Santoliquido A, Santoro L, Bernabei R, Landi F., BMJ Open 8(6), 2018
PMID: 29961030
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels.
Schettler VJ, Neumann CL, Peter C, Zimmermann T, Julius U, Roeseler E, Heigl F, German Apheresis Working Group., Clin Res Cardiol Suppl 10(), 2015
PMID: 25652812
[Prevalence of dyslipidemia among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS 1)].
Scheidt-Nave C, Du Y, Knopf H, Schienkiewitz A, Ziese T, Nowossadeck E, Gößwald A, Busch MA., Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(5-6), 2013
PMID: 23703484
Prevalence of the seven cardiovascular health metrics in a Mediterranean country: results from a cross-sectional study.
Vetrano DL, Martone AM, Mastropaolo S, Tosato M, Colloca G, Marzetti E, Onder G, Bernabei R, Landi F., Eur J Public Health 23(5), 2013
PMID: 24078648
Treatment of hypertension in Germany: is there a social gradient?
Laaser U, Breckenkamp J, Bjegovic V., Int J Public Health 57(1), 2012
PMID: 21735118
Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007.
Estoppey D, Paccaud F, Vollenweider P, Marques-Vidal P., BMC Public Health 11(), 2011
PMID: 21332996
Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany.
Fiss T, Ritter CA, Alte D, van den Berg N, Hoffmann W., Pharm World Sci 32(5), 2010
PMID: 20593238
Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
Linnemann B, Zgouras D, Schindewolf M, Schwonberg J, Jarosch-Preusche M, Lindhoff-Last E., Blood Coagul Fibrinolysis 19(2), 2008
PMID: 18277138

31 References

Daten bereitgestellt von Europe PubMed Central.


AUTHOR UNKNOWN, 0
Intermittent claudication. A risk profile from The Framingham Heart Study.
Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF., Circulation 96(1), 1997
PMID: 9236415
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.
D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB., Stroke 25(1), 1994
PMID: 8266381
An updated coronary risk profile. A statement for health professionals.
Anderson KM, Wilson PW, Odell PM, Kannel WB., Circulation 83(1), 1991
PMID: 1984895

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.
Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ., N. Engl. J. Med. 333(20), 1995
PMID: 7566020

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
Ostrava--a new endemic focus of Mycobacteria xenopi in the Czech Republic.
Kaustova J, Charvat B, Mudra R, Holendova E., Cent. Eur. J. Public Health 1(1), 1993
PMID: 8305886

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
National trends in risk factors for cardiovascular disease in Germany.
Hoffmeister H, Mensink GB, Stolzenberg H., Prev Med 23(2), 1994
PMID: 8047526

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
The association of changes in physical-activity level and other lifestyle characteristics with mortality among men.
Paffenbarger RS Jr, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB., N. Engl. J. Med. 328(8), 1993
PMID: 8426621

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 16093306
PubMed | Europe PMC

Suchen in

Google Scholar